Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SLXN will decline by -94.68% over the next 2 Weeks and hit $0.01 by Tuesday, June 2, 2026. In that time frame, SLXN's share price is expected to range between $0.00 and $0.11.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 2, 2026 | 0.00 | 0.01 | 0.11 |
| Jun 1, 2026 | 0.00 | 0.01 | 0.11 |
| May 29, 2026 | 0.00 | 0.03 | 0.12 |
| May 28, 2026 | 0.00 | 0.09 | 0.18 |
| May 27, 2026 | 0.03 | 0.12 | 0.22 |
| May 26, 2026 | 0.05 | 0.14 | 0.23 |
| May 25, 2026 | 0.05 | 0.14 | 0.24 |
| May 22, 2026 | 0.06 | 0.16 | 0.25 |
| May 21, 2026 | 0.12 | 0.22 | 0.32 |
| May 20, 2026 | 0.16 | 0.25 | 0.33 |
SLXN shares rose +96.95% in Wednesday, May 20, 2026's trading session, rising from a previous close of $0.27 to move at $0.53. The stock demonstrated notable intraday movement (see SLXN's key stats for a full breakdown), fluctuating between $0.37 and $0.67, a +82.07% trading range. While recent weeks have seen some volatility, SLXN has managed to secure a +2.08% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 326.86M shares changing hands, 326.08M more than the previous session. This amounted to $173.17M in total market activity.
Will SLXN Continue Its Downward Trend?
According to analyst ratings and projections for SLXN, Silexion Therapeutics Ltd. shares are anticipated to decrease by -389.34%, potentially reaching $0.11 per share by June 2, 2026. Short-term technical indicators for SLXN currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 23 negative trading days within the past 30 sessions. Based on the SLXN stock forecast, now is not the best time to buy SLXN stock because its current trading price is +3,604.90% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SLXN covering social and institutional perspectives.
SLXN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SLXN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.34% to 48.90%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 37.04%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 37.24%, signals a bearish bias in the long-term trend. Insights into SLXN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Silexion Therapeutics Short-Term Forecasts
SLXN Forecast For Next 5 Days
Our algorithm anticipates Silexion Therapeutics (SLXN) stock could hit $0.25 by May 27, 2026. This represents a -53.00% rise from today's price, following a +5.66% change over the past five days.
SLXN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Silexion Therapeutics Ltd. (SLXN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.19, which would mean a -64.14% decrease from the current price of $0.53. Projections for this period range from a high of $0.40 to a low of $0.00.
SLXN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Silexion Therapeutics's price over the next three months point to a drop. SLXN stock is expected to peak at $29.32 on Jun 30, 2026 before potentially dipping to $0.00 on Aug 20, 2026. On average, SLXN is likely to trade around $0.00 in the coming 90 days.
Silexion Therapeutics Stock Forecast 2025
Based on our predictive models, Silexion Therapeutics (SLXN) is expected to trade between $0.00 and $31.38 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
Silexion Therapeutics Ltd. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Silexion Therapeutics Ltd. (SLXN) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.00 and $27.42, settling at an average of $0.00. This could translate to a -100.00% loss.
June 2026
Based on current market signals, Silexion Therapeutics Ltd. is projected to trend june 2026. We forecast a trading range from $0.00 to $29.32, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
July 2026
Our predictive algorithms indicate Silexion Therapeutics Ltd. stock may see a shift in July 2026. The expected range spans $0.00–$28.67, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
August 2026
Analyzing established trends, Silexion Therapeutics Ltd. looks set to move in August 2026. Projections place the stock between $0.00 and $27.46, averaging around $0.00. This suggests a -100.00% loss from current levels.
September 2026
Market indicators suggest Silexion Therapeutics Ltd. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $29.05, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
October 2026
Forecasting for October 2026, models estimate that Silexion Therapeutics Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $30.40, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
November 2026
According to our latest forecast models, Silexion Therapeutics Ltd. (SLXN) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $31.38, settling at an average of $0.00. This could translate to a -100.00% loss.
December 2026
Based on current market signals, Silexion Therapeutics Ltd. is projected to trend december 2026. We forecast a trading range from $0.00 to $30.83, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
January 2027
Our predictive algorithms indicate Silexion Therapeutics Ltd. stock may see a shift in January 2027. The expected range spans $0.00–$30.42, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
February 2027
Analyzing established trends, Silexion Therapeutics Ltd. looks set to move in February 2027. Projections place the stock between $0.00 and $28.88, averaging around $0.00. This suggests a -100.00% loss from current levels.
March 2027
Market indicators suggest Silexion Therapeutics Ltd. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $29.99, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
April 2027
Forecasting for April 2027, models estimate that Silexion Therapeutics Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $32.01, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
May 2027
According to our latest forecast models, Silexion Therapeutics Ltd. (SLXN) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $31.12, settling at an average of $0.00. This could translate to a -100.00% loss.
SLXN's history of dividends and stock splits also plays a role in long-term investor confidence.